La cadena de opciones muestra datos clave de las opciones de acciones de CCSC Technology a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para CCSC Technology..

CCSC Technology (NASDAQ:CCTG) Bolsa, Cadena de Opciones

CCSC Technology

CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.

CCSC Technology International Holdings Limited - Class A Ordinary Shares

CCSC Technology International Holdings Ltd

Barclays analyst Ramsey El-Assal maintains Remitly Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELY#NASDAQ">RELY</a>) with a Overweight and raises the price target from $20 to $23.

News

Price Target

Analyst Ratings

RELY

Barclays Maintains Overweight on Remitly Global, Raises Price Target to $23

BMO Capital analyst Kelly Bania maintains Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Market Perform and lowers the price target from $90 to $80.

BMO Capital Maintains Market Perform on Dollar Gen, Lowers Price Target to $80

Barclays analyst John Coffey maintains StoneCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) with a Equal-Weight and lowers the price target from $13 to $12.

STNE

Barclays Maintains Equal-Weight on StoneCo, Lowers Price Target to $12

BMO Capital analyst Kelly Bania maintains Dollar Tree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) with a Market Perform and lowers the price target from $68 to $65.

DLTR

BMO Capital Maintains Market Perform on Dollar Tree, Lowers Price Target to $65

Wedbush analyst David Nierengarten reiterates Intellia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) with a Neutral and maintains $14 price target.

Reiteration

NTLA

Wedbush Reiterates Neutral on Intellia Therapeutics, Maintains $14 Price Target

Barclays analyst Simon Coles maintains Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) with a Overweight and raises the price target from $215 to $240.

Barclays Maintains Overweight on Taiwan Semiconductor, Raises Price Target to $240

BMO Capital analyst Kelly Bania maintains Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) with a Outperform and raises the price target from $980 to $1075.

COST

BMO Capital Maintains Outperform on Costco Wholesale, Raises Price Target to $1075

Trading Ideas

PLAG

Planet Green Holdings Shares Halted To The Downside; Stock Now Down -4.42%

Wedbush analyst Nick Setyan maintains Jack In The Box (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JACK#NASDAQ">JACK</a>) with a Outperform and lowers the price target from $60 to $50.

JACK

Wedbush Maintains Outperform on Jack In The Box, Lowers Price Target to $50

BMO Capital analyst Kelly Bania maintains Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) with a Outperform and raises the price target from $80 to $100.

BMO Capital Maintains Outperform on Walmart, Raises Price Target to $100

Biotech

General

BBIO

BridgeBio Pharma Says The Continued Curve Separation Of The Composite Endpoint Of ACM And Recurrent Cardiovascular-Related Hospitalizations Emphasizes The Importance Of Early Intervention Resulting In Early And Sustained Clinical Benefits, With Acoramidis Demonstrating 46% And 48% Reductions In The Composite Endpoint Of ACM And Recurrent CVH At Months 36 And 42, Respectively

- Acoramidis demonstrated the earliest known time to separation in cardiovascular outcomes in the ATTRibute-CM study (3 months), with statistically significant risk reduction of 36% on All-Cause Mortality (ACM) alone at Month 36 within the Open Label Extension
- The continued curve separation of the composite endpoint of ACM and recurrent cardiovascular-related hospitalizations (CVH) emphasizes the importance of early intervention resulting in early and sustained clinical benefits, with acoramidis demonstrating 46% (p&lt;0.0001) and 48% (p&lt;0.0001) reductions in the composite endpoint of ACM and recurrent CVH at Months 36 and 42, respectively
- The preliminary results from this ongoing OLE study were also <a href="https://www.globenewswire.com/Tracker?data=nVrCQc_8jzuW0us-lfgFaR1qVTq_ZKK094j0nAXwGOzjpiNvmiPryHA11xPFHhBaYgKeFEBHeF4VNpSc_nsfEV21llyp7gkCWZiQNzvNSBAxj8g76mpygGVWg7b6bJ3rrNNv9OwALUuytnCVMDnjfDM4znS65x927SjyqqRsPQ4YxLUlnW0b98_MjiwYp5E1">simultaneously published in&nbsp;Circulation</a>
- A New Drug Application for acoramidis for the treatment of ATTR-CM is currently under review with the FDA, with a PDUFA action date of November 29, 2024
PALO ALTO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) ("BridgeBio" or the "Company"), a&nbsp;new type of biopharmaceutical company focused on genetic diseases, presented positive initial outcomes from the ATTRibute-CM open-label extension (OLE) study of acoramidis in ATTR-CM at the American Heart Association (AHA) Scientific Sessions. ATTRibute-CM was designed to evaluate the efficacy and safety of acoramidis, an investigational, near-complete, orally-administered, small molecule stabilizer of TTR. The preliminary results from this ongoing OLE study were also <a href="https://www.globenewswire.com/Tracker?data=nVrCQc_8jzuW0us-lfgFaR1qVTq_ZKK094j0nAXwGOzjpiNvmiPryHA11xPFHhBaeIlDqZKG7OqhCoe56sd754bjgDVGcOiJ2s8HyuUyG7NflQCmEEQ3lIVaCQMHailwHLZaiAioFHGbJQ3YCr7zBvPyWKH7hTdh2uwLa8ooRVkFlNr8o40ZFfvRncYmj6k3">simultaneously published in&nbsp;Circulation</a>. The OLE study involves 330 participants who completed the 30-month ATTRibute-CM Phase 3 study.

BridgeBio Pharma Presented Initial Outcomes From The ATTRibute-CM Open-label Extension Study Of Acoramidis In ATTR-CM At The AHA Scientific Sessions; Acoramidis Demonstrated The Earliest Known Time To Separation In Cardiovascular Outcomes In The  ATTRibute-CM Study (3 Months), With Statistically Significant Risk Reduction Of 36% On All-Cause Mortality Alone At Month 36 Within The Open Label Extension

BMO Capital analyst James Thalacker maintains Entergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) with a Outperform and lowers the price target from $166 to $159.

BMO Capital Maintains Outperform on Entergy, Lowers Price Target to $159

Benchmark analyst Nathan Martin reiterates Arch Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARCH#NYSE">ARCH</a>) with a Buy and maintains $180 price target.

ARCH

Benchmark Reiterates Buy on Arch Resources, Maintains $180 Price Target

Many Senate Republicans want the House Ethics Committee report on Matt Gaetz to be released. Gaetz is a close ally of President-elect Donald Trump.
<a href="https://www.cnbc.com/2024/11/18/trump-ag-matt-gaetz-house-ethics-panel-report-meeting.html" title="https://www.cnbc.com/2024/11/18/trump-ag-matt-gaetz-house-ethics-panel-report-meeting.html">https://www.cnbc.com/2024/11/18/trump-ag-matt-gaetz-house-ethics-panel-report-meeting.html</a> &nbsp;

Politics

'House Ethics panel to meet on Trump attorney general pick Matt Gaetz report Wednesday' - CNBC

Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) promises discounts and exclusive offers <a href="https://www.benzinga.com/topic/holidays">this holiday shopping season</a>. 
The retailer aims to offer an enhanced shopping experience, both online and in stores, with early access for Walmart+ members.
Starting at noon ET on Nov. 25, Walmart+ members will get a head start on Black Friday deals before the general public at 5 p.m. ET. Walmart&#8217;s holiday sales will feature steep discounts across top categories like electronics, toys, and fashion, with doorbuster deals available in-store from 6 a.m. local time on Black Friday.
Walmart promises savings across brands like Reebok, Michael Kors, and Dyson. Highlighted deals include: 
<ul>
<li>Dyson V11 Extra Cordless Vacuum Cleaner for $349.99, saving shoppers $250 off the regular price. </li>
<li>A TCL 65-inch 4K UHD Smart TV for $228, a discount of $301.</li>
<li>A Restored Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) MacBook Air bundle priced at $194, saving $81.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/news/earnings/24/11/42031958/niu-q3-earnings-scooter-volume-up-but-price-drops-and-margins-tighten-strong-q4-outlook-and-more" target="_blank" rel="noreferrer noopener">Niu Q3 Earnings: Scooter Volume Up, But Price Drops And Margins Tighten, Strong Q4 Outlook And More</a>
Sign-ups are available for a discounted annual fee of $49 until Dec. 2. This membership perk provides early shopping windows for Black Friday and Cyber Monday events and other exclusive offers throughout the holiday season.
Walmart&#8217;s Cyber Monday deals will start on Sunday, Dec. 1, at 5 p.m. ET for Walmart+ members and at 8 p.m. ET for all customers. 
Featured deals include: 
<ul>
<li>The $898 Sony Group Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) 75-inch BRAVIA 4K HDR LED TV, a savings of $600.</li>
<li>The $98 Ninja Grand Kitchen System and the $48.98 LEGO Star Wars Darth Vader Helmet.</li>
</ul>
Walmart has enhanced its holiday shopping features, offering customers a personalized search experience, expanded delivery options, and the ability to schedule delivery for large items. 
This year, Walmart also partnered with Angi for convenient installation services, including home décor and TV setups, catering to various holiday needs.
Amazon.Com Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) U.S. sales on Cyber Monday reached <a href="https://www.benzinga.com/news/24/10/41185124/amazon-to-boost-workforce-by-250k-for-2024-holidays-joining-retail-hiring-surge">$12.4 billion in 2023</a>, rising 9.6% and surpassing the $12 billion forecast. Total online sales for Cyber Week hit $38 billion, exceeding the $37.2 billion estimate.
Bank of America analyst Robert Ohmes predicted strong third-quarter results.
Ohmes expects Walmart&#8217;s third-quarter earnings per share to reach $0.52, driven by grocery and <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41913981/what-to-expect-from-walmarts-q3-earnings" rel="noreferrer noopener">health/wellness sales growth</a>. Walmart&#8217;s store remodels, online product expansion, and express delivery upgrades boost sales and customer loyalty. Despite a shorter holiday season, Walmart&#8217;s strong digital and omni-channel offerings could see increased online sales.
Walmart faces risks from Trump&#8217;s tariff plans, which may raise costs and challenge its low-price strategy.
Tax cuts enable Walmart to reinvest in technology, strengthening its edge against rivals like Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>).
Investors can gain exposure to Walmart through SPDR S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and iShares Core S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVV#NYSE">IVV</a>).
Price Action: WMT stock is up 0.53% at $84.70 premarket at last check Monday. Walmart stock surged 59% year-to-date.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/tech/24/11/41978712/asml-projects-revenue-surge-to-63-billion-by-2030-eyes-ai-and-chip-market-boom" target="_blank" rel="noreferrer noopener">ASML Projects Revenue Surge to $63 Billion by 2030, Eyes AI and Chip Market Boom</a></li>
</ul>

AAPL

AMZN

Sony Group Corporation American Depositary Shares

SONY

Walmart Gears Up For Black Friday, Cyber Monday Specials: Major Discounts On Apple MacBooks, Sony TVs

Deep-pocketed investors have adopted a bullish approach towards Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in HIMS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 28 extraordinary options activities for Hims &amp; Hers Health. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 71% leaning bullish and 14% bearish. Among these notable options, 12 are puts, totaling $960,282, and 16 are calls, amounting to $827,190.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $15.0 and $42.0 for Hims &amp; Hers Health, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Hims &amp; Hers Health's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hims &amp; Hers Health's whale activity within a strike price range from $15.0 to $42.0 in the last 30 days. 
<h3>Hims &amp; Hers Health Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731946560_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$5.4</td>
<td>$5.3</td>
<td>$5.3</td>
<td>$25.00</td>
<td>$208.8K</td>
<td>3.5K</td>
<td>1.7K</td>
</tr>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/29/24</td>
<td>$1.5</td>
<td>$1.4</td>
<td>$1.44</td>
<td>$20.50</td>
<td>$147.0K</td>
<td>2.0K</td>
<td>2.3K</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.35</td>
<td>$1.25</td>
<td>$1.34</td>
<td>$28.00</td>
<td>$132.7K</td>
<td>2.7K</td>
<td>1.2K</td>
</tr>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.45</td>
<td>$2.4</td>
<td>$2.4</td>
<td>$20.00</td>
<td>$120.0K</td>
<td>6.2K</td>
<td>989</td>
</tr>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$2.5</td>
<td>$2.4</td>
<td>$2.45</td>
<td>$21.00</td>
<td>$113.9K</td>
<td>5.2K</td>
<td>480</td>
</tr>
</tbody>
</table>

<h3>About Hims &amp; Hers Health</h3>
Hims &amp; Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
In light of the recent options history for Hims &amp; Hers Health, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Hims &amp; Hers Health</h3>
<ul>
<li>Currently trading with a volume of 10,964,198, the HIMS's price is up by 12.73%, now at $21.78. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 98 days.</li>
</ul>
<h3>What Analysts Are Saying About Hims &amp; Hers Health</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $23.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from B of A Securities downgraded its rating to Underperform, setting a price target of $18. 
&#x2A; Reflecting concerns, an analyst from Piper Sandler lowers its rating to Neutral with a new price target of $21. 
&#x2A; An analyst from Canaccord Genuity persists with their Buy rating on Hims &amp; Hers Health, maintaining a target price of $28. 
&#x2A; An analyst from Deutsche Bank has decided to maintain their Hold rating on Hims &amp; Hers Health, which currently sits at a price target of $27. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Hims &amp; Hers Health with a target price of $25. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Hims &amp; Hers Health, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Unpacking the Latest Options Trading Trends in Hims & Hers Health

<a href="https://www.benzinga.com/24/11/41947081/kevin-oleary-says-great-entrepreneurs-and-great-leaders-want-to-get-up-in-the-morning-and-get-to-work-heres-what-he-says-drives-them">Kevin O&#8217;Leary</a> recently appeared on The Daniela Cambone Show, where he discussed the current state of the U.S. energy sector and broader market trends. O&#8217;Leary, known for his outspoken views on business and investment, shared his thoughts on how regulatory changes under the Biden-Harris administration have impacted the economy, particularly in energy and how markets are reacting now.
Don't Miss:
<ul>
<li>With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai-2">Be an early investor with just $1,000 for only $0.50/share today before the offer closes in the next few days</a>!</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">You can still get 4,000 of its pre-IPO shares for with $1,000 for just $0.25/share</a></li>
</ul>
O&#8217;Leary made it clear that a lot of the recent market movement is due to what he sees as the lifting of &#8220;a trillion dollars worth of regulatory pressure.&#8221; Reflecting on the <a href="https://www.benzinga.com/personal-finance/24/11/42013651/is-trumps-second-term-going-to-affect-student-loan-borrowers-here-are-3-potential-changes">Trump administration</a>, he explained how previous deregulation policies benefited multiple industries, especially energy.&nbsp;
"Trump stripped away a lot of the regulation and energy was a huge beneficiary," O&#8217;Leary said. According to him, this helped energy companies thrive, creating a more open environment for growth and expansion.
However, O&#8217;Leary also pointed out how the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41976407/ben-horowitz-the-biden-regulators-lied-about-crypto">Biden administration&#8217;s policies</a> reversed some of that. He specifically mentioned how regulations were added to the energy sector, which, in his view, made things harder.&nbsp;
Trending: This rooftop wind turbine is taking on a market projected to reach over $900 billion by 2032 —<a href="https://www.benzinga.com/money/halcium"> With already over 40,000 users signing up to purchase, here's a chance to be an early investor today!</a>
"Biden-Harris, whether you liked them or not, added a lot of layers of administration and regulation," he said. He noted that natural gas exports were halted and new energy permits became harder to obtain. According to O&#8217;Leary, these measures had a cooling effect on the energy sector. "They made it difficult for companies to expand or even get new projects started," he added.
Despite these setbacks, O&#8217;Leary believes the market mood is improving. &#8220;The market's celebrating a more positive view of expansion,&#8221; he said. This shift is partly due to the hope that the regulatory environment might become more business-friendly. With the lifting of certain restrictions, O'Leary believes energy companies and other sectors are seeing more growth opportunities again.
O&#8217;Leary also discussed other sectors benefiting from changes in the regulatory landscape, including the <a href="https://www.benzinga.com/media/24/11/42022531/cathie-wood-backs-elon-musks-2-trillion-doge-initiative-says-tesla-ceos-access-to-proprietary-data-and-ai-gives-him-an-edge">cryptocurrency market</a>. In particular, he commented on the recent rumors surrounding the Commodity Futures Trading Commission (CFTC) potentially taking over crypto regulation from the Securities and Exchange Commission (SEC).&nbsp;
See Also: The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a>
O&#8217;Leary remarked that the SEC's litigious approach to regulation may have hindered growth in the digital currency space and that fewer regulations would have been positive.
O&#8217;Leary also shared his optimism about technology and finance, particularly digital payments. "I'm a big believer in digital payment systems beyond just tokens and Bitcoin," he said. He sees these systems as essential for the future of global finance, offering potential far beyond what we currently see in the world of cryptocurrencies.
In a final reflection, O&#8217;Leary noted that democracy has a way of correcting itself. "When things get too crazy, to the left, to the right, it somehow figures out how to fix itself," he said.&nbsp;
Read Next:
<ul>
<li>This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> here's how there's a limited time opportunity to invest at $1,000 for only $0.50/share before it closes in a few days.</a></li>
<li>‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a></li>
</ul>

Startups

Kevin O'Leary: 'Biden-Harris Regulations Held Back Energy, But Markets Now Celebrate Expansion'

Deep-pocketed investors have adopted a bullish approach towards Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Goldman Sachs Gr. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 40% leaning bullish and 40% bearish. Among these notable options, 2 are puts, totaling $70,260, and 8 are calls, amounting to $477,053.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $300.0 and $620.0 for Goldman Sachs Gr, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Goldman Sachs Gr's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Goldman Sachs Gr's whale trades within a strike price range from $300.0 to $620.0 in the last 30 days. 
<h3>Goldman Sachs Gr Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731946555_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$30.2</td>
<td>$30.15</td>
<td>$30.2</td>
<td>$590.00</td>
<td>$141.9K</td>
<td>74</td>
<td align="right">51</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$171.15</td>
<td>$171.05</td>
<td>$171.0</td>
<td>$430.00</td>
<td>$68.4K</td>
<td>1.1K</td>
<td align="right">47</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$293.0</td>
<td>$292.3</td>
<td>$293.0</td>
<td>$300.00</td>
<td>$58.6K</td>
<td>74</td>
<td align="right">2</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$171.3</td>
<td>$169.55</td>
<td>$169.91</td>
<td>$430.00</td>
<td>$50.9K</td>
<td>1.1K</td>
<td align="right">27</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$171.3</td>
<td>$169.3</td>
<td>$169.91</td>
<td>$430.00</td>
<td>$50.9K</td>
<td>1.1K</td>
<td align="right">24</td>
</tr>
</tbody>
</table>

<h3>About Goldman Sachs Gr</h3>
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 20% of its revenue comes from investment banking, 45% from trading, 20% from asset management and 15% from wealth management and retail financial services. Around 60% of the company's net revenue is generated in the Americas, 15% in Asia, and 25% in Europe, the Middle East, and Africa.
In light of the recent options history for Goldman Sachs Gr, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Goldman Sachs Gr Standing Right Now?</h3>
<ul>
<li>With a trading volume of 414,407, the price of GS is down by -0.52%, reaching $590.47.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 58 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Goldman Sachs Gr</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $670.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Oppenheimer persists with their Outperform rating on Goldman Sachs Gr, maintaining a target price of $661. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Goldman Sachs Gr, which currently sits at a price target of $680. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Goldman Sachs Gr, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Looking At Goldman Sachs Gr's Recent Unusual Options Activity

Whales with a lot of money to spend have taken a noticeably bullish stance on Salesforce.
Looking at options history for Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) we detected 38 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 44% with bearish.
From the overall spotted trades, 15 are puts, for a total amount of $976,938 and 23, calls, for a total amount of $1,067,057.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $200.0 to $340.0 for Salesforce over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Salesforce's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Salesforce's whale trades within a strike price range from $200.0 to $340.0 in the last 30 days. 
<h3>Salesforce Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731946550_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$7.7</td>
<td>$6.9</td>
<td>$7.7</td>
<td>$330.00</td>
<td>$291.0K</td>
<td>511</td>
<td align="right">514</td>
</tr>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$7.8</td>
<td>$7.75</td>
<td>$7.8</td>
<td>$330.00</td>
<td>$87.3K</td>
<td>511</td>
<td align="right">120</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$16.95</td>
<td>$16.75</td>
<td>$16.75</td>
<td>$330.00</td>
<td>$83.7K</td>
<td>1.4K</td>
<td align="right">70</td>
</tr>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$28.55</td>
<td>$28.2</td>
<td>$28.2</td>
<td>$340.00</td>
<td>$76.1K</td>
<td>57</td>
<td align="right">30</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$107.3</td>
<td>$105.5</td>
<td>$107.17</td>
<td>$220.00</td>
<td>$74.9K</td>
<td>1.0K</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Salesforce</h3>
Salesforce provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Following our analysis of the options activities associated with Salesforce, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Salesforce</h3>
<ul>
<li>With a volume of 1,091,100, the price of CRM is down -0.47% at $323.72. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 15 days.</li>
</ul>
<h3>What The Experts Say On Salesforce</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $369.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Salesforce, which currently sits at a price target of $330. 
&#x2A; An analyst from BMO Capital has decided to maintain their Outperform rating on Salesforce, which currently sits at a price target of $385. 
&#x2A; An analyst from Loop Capital has decided to maintain their Hold rating on Salesforce, which currently sits at a price target of $340. 
&#x2A; Maintaining their stance, an analyst from Jefferies continues to hold a Buy rating for Salesforce, targeting a price of $400. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Salesforce with a target price of $390. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Salesforce options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

A Closer Look at Salesforce's Options Market Dynamics

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday!



Moving stocks this morning are business combinations, earnings reports, and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) stock is rocketing more than 39% alongside heavy pre-market trading.</li>



<li>First Wave BioPharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/fwbi-stock-quote/">FWBI</a>) shares are soaring over 33% after <a href="https://www.globenewswire.com/news-release/2024/03/14/2846098/0/en/First-Wave-BioPharma-Announces-Completion-of-Business-Combination-with-ImmunogenX-Adding-Phase-3-Ready-Latiglutenase-to-its-Late-Stage-GI-Focused-Clinical-Pipeline.html">completing a business combination</a>.</li>



<li>Turtle Beach (NASDAQ:<a href="https://investorplace.com/stock-quotes/hear-stock-quote/">HEAR</a>) stock is surging more than 28% after announcing <a href="https://www.nasdaq.com/press-release/turtle-beach-announces-transformational-acquisition-of-pdp-and-intention-to-launch">acquisition plans for PDP</a>.</li>



<li>CCSC Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/cctg-stock-quote/">CCTG</a>) shares are increasing over 26%, with strong early morning trading this morning.</li>



<li>ShiftPixy (NASDAQ:<a href="https://investorplace.com/stock-quotes/pixy-stock-quote/">PIXY</a>) stock is gaining more than 21% as it <a href="https://investorplace.com/2024/03/why-is-shiftpixy-pixy-stock-up-52-today/">continues a recent rally</a>.</li>



<li>DHC Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/dhca-stock-quote/">DHCA</a>) shares are rising close to 21% on <a href="https://www.businesswire.com/news/home/20240313400845/en/BEN-Announces-Expected-Closing-of-Business-Combination">plans to close a business combination</a>.</li>



<li>BOS Better Online Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/bosc-stock-quote/">BOSC</a>) stock is climbing nearly 19% this morning.</li>



<li>Spero Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/spro-stock-quote/">SPRO</a>) shares are heading over 18% higher with a <a href="https://finance.yahoo.com/news/spero-therapeutics-inc-spro-q4-211003604.html">positive Q4 earnings report</a>.</li>



<li>Ucloudlink (NASDAQ:<a href="https://investorplace.com/stock-quotes/ucl-stock-quote/">UCL</a>) stock is jumping more than 17% after <a href="https://www.nasdaq.com/press-release/ucloudlink-group-inc.-announces-unaudited-fourth-quarter-and-full-year-2023-financial">releasing its Q4 earnings report</a>.</li>



<li>New Horizon Aircraft (NASDAQ:<a href="https://investorplace.com/stock-quotes/hovr-stock-quote/">HOVR</a>) shares are up over 14% <a href="https://www.nasdaq.com/press-release/horizon-aircraft-to-participate-in-the-36th-annual-roth-conference-on-march-18-and-19">ahead of a conference next week</a>.</li>
</ol><h2>Top 10 Losers</h2>



<ol><li>Spruce Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/sprb-stock-quote/">SPRB</a>) stock is crashing more than 73% alongside its <a href="https://finance.yahoo.com/news/spruce-biosciences-reports-full-2023-200800244.html">latest earnings report</a> and <a href="https://finance.yahoo.com/news/spruce-biosciences-announces-topline-results-200100871.html">clinical trial data</a>.</li>



<li>Fisker (NYSE:<a href="https://investorplace.com/stock-quotes/fsr-stock-quote/">FSR</a>) stock is plummeting over 38% on reports its <a href="https://www.wsj.com/business/autos/electric-vehicle-startup-fisker-prepares-for-possible-bankruptcy-filing-26e63d32">considering a bankruptcy filing</a>.</li>



<li>Solidion Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/sti-stock-quote/">STI</a>) shares are diving more than 34% after <a href="https://www.nasdaq.com/press-release/solidion-technology-inc.-announces-pricing-of-%243.85-million-private-placement-2024-03">pricing a private placement</a>.</li>



<li>Hello (NASDAQ:<a href="https://investorplace.com/stock-quotes/momo-stock-quote/">MOMO</a>) stock is tumbling over 16% with the release of its <a href="https://www.nasdaq.com/press-release/hello-group-inc.-announces-unaudited-financial-results-for-the-fourth-quarter-and-1">Q4 earnings report</a>.</li>



<li>Pagaya Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/pgy-stock-quote/">PGY</a>) shares are taking a more than 14% beating after <a href="https://finance.yahoo.com/news/pagaya-announces-public-offering-class-204000211.html">announcing a public offering</a>.</li>



<li>Erayak Power Solution (NASDAQ:<a href="https://investorplace.com/stock-quotes/raya-stock-quote/">RAYA</a>) stock is sliding over 14% this morning.</li>



<li>Qilian (NASDAQ:<a href="https://investorplace.com/stock-quotes/qli-stock-quote/">QLI</a>) shares are decreasing more than 13% on Thursday morning.</li>



<li>PLBY Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/plby-stock-quote/">PLBY</a>) stock is dropping over 13% after <a href="https://ca.investing.com/news/stock-market-news/plby-group-to-restate-financials-reducing-net-losses-93CH-3299860">restating financial results</a>.</li>



<li>Assure (NASDAQ:<a href="https://investorplace.com/stock-quotes/ionm-stock-quote/">IONM</a>) shares are falling more than 13% this morning.</li>



<li>Global Gas (NASDAQ:<a href="https://investorplace.com/stock-quotes/hgas-stock-quote/">HGAS</a>) stock closes our out pre-market stock movers down over 13%.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/03/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-march-14th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Blade Air Mobility, NuScale Power, XTI Aerospace among industrial movers

PERI, ITRM and CADL among pre-market losers

CCSC Technology International Holdings Limited (CCTG) has released an update. CCSC Technology International Holdings Limited has appointed a new Ch...

CCSC Appoints New Chief Strategy Officer

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Wednesday as we offer up all the latest news sending shares higher and lower this morning!



Moving stocks this morning are continued rallies, heavy trading, clinical trials and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Akoustis Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/akts-stock-quote/">AKTS</a>) stock is rocketing more than 142% alongside heavy pre-market trading.</li>



<li>Mustang Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/mbio-stock-quote/">MBIO</a>) shares are soaring over 82% with strong early morning trading.</li>



<li>MGO Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgol-stock-quote/">MGOL</a>) stock is surging more than 68% as it <a href="https://investorplace.com/2024/05/why-is-mgo-global-mgol-stock-up-106-today/">continues to rally</a>.</li>



<li>Barnes &amp; Noble Education (NYSE:<a href="https://investorplace.com/stock-quotes/bned-stock-quote/">BNED</a>) shares are gaining close to 54% as its <a href="https://investorplace.com/2024/05/what-is-going-on-with-barnes-noble-education-bned-stock-today/">rally yesterday continues</a>.</li>



<li>Rezolute (NASDAQ:<a href="https://investorplace.com/stock-quotes/rzlt-stock-quote/">RZLT</a>) stock is rising over 31% after <a href="https://www.nasdaq.com/press-release/rezolute-reports-positive-topline-results-from-phase-2-proof-of-concept-study-of">releasing positive study results</a>.</li>



<li>DermTech (NASDAQ:<a href="https://investorplace.com/stock-quotes/dmtk-stock-quote/">DMTK</a>) shares are increasing more than 28% with heavy trading this morning.</li>



<li>Mangoceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgrx-stock-quote/">MGRX</a>) stock is heading over 22% higher after <a href="https://investorplace.com/2024/05/why-is-mangoceuticals-mgrx-stock-up-130-today/">rallying yesterday too</a>.</li>



<li>VS Media (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsme-stock-quote/">VSME</a>) shares are climbing more than 19% without any clear news this morning.</li>



<li>Eupraxia Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/eprx-stock-quote/">EPRX</a>) stock is jumping over 15% on <a href="https://www.marketwatch.com/story/eupraxia-pharmaceuticals-shares-pop-after-new-trial-data-4e20f13b?mod=newsviewer_click">new drug trial data</a>.</li>



<li>CCSC Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/cctg-stock-quote/">CCTG</a>) shares are up more than 15% despite a lack of news.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Crown ElectroKinetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/crkn-stock-quote/">CRKN</a>) stock is diving over 24% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318339015&amp;type=PDF&amp;symbol=CRKN&amp;cdn=9fd92bcd34f4f2180730286b7103ecb0&amp;companyName=Crown+Electrokinetics+Corp.&amp;formType=DEF+14A&amp;formDescription=Other+definitive+proxy+statements&amp;dateFiled=2024-05-21">announcing shareholder meeting plans</a>.</li>



<li>Edible Garden (NASDAQ:<a href="https://investorplace.com/stock-quotes/edbl-stock-quote/">EDBL</a>) shares are tumbling more than 24% without any apparent news to report.</li>



<li>Euronav (NYSE:<a href="https://investorplace.com/stock-quotes/eurn-stock-quote/">EURN</a>) stock is taking an over 20% beating on no clear news this morning.</li>



<li>Sintx Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/sint-stock-quote/">SINT</a>) shares are sliding nearly 19% on Wednesday morning.</li>



<li>FLJ Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/flj-stock-quote/">FLJ</a>) stock is dropping more than 16% this morning.</li>



<li>Cheetah Net Supply Chain (NASDAQ:<a href="https://investorplace.com/stock-quotes/ctnt-stock-quote/">CTNT</a>) shares are falling over 16% as they continue to drop.</li>



<li>LifeStance Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/lfst-stock-quote/">LFST</a>) stock is decreasing more than 15% after <a href="https://www.nasdaq.com/press-release/lifestance-health-group-announces-pricing-of-secondary-public-offering-2024-05-21">pricing a secondary offering</a>.</li>



<li>Chijet Motor (NASDAQ:<a href="https://investorplace.com/stock-quotes/cjet-stock-quote/">CJET</a>) shares are dipping over 15% after rallying yesterday.</li>



<li>Meta Data (NYSE:<a href="https://investorplace.com/stock-quotes/aiu-stock-quote/">AIU</a>) stock is slipping more than 15% today.</li>



<li>Vicarious Surgical (NYSE:<a href="https://investorplace.com/stock-quotes/rbot-stock-quote/">RBOT</a>) shares close out our pre-market stock movers down over 14% on a <a href="https://www.investing.com/news/company-news/vicarious-surgical-ceo-sells-shares-worth-9506-93CH-3450561">CEO share sale</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-may-22nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Greenwave Technology, FREYR Battery, Golden Ocean among industrial movers

IPO Roundup: Ardent Health, TWFG, Artiva Biotherapeutics, and more

CCSC Technology International Holdings GAAP EPS of -$0.13, revenue of $14.7M

CCSC Technology International Holdings Limited (CCTG) has released an update. CCSC Technology International Holdings Limited has announced its Annu...

CCSC Technology International's Key AGM Proposals

CCSC Technology International Holdings Limited (CCTG) has released an update. CCSC Technology International Holdings Limited recently convened its ...

CCSC Technology Shareholders Approve Key Resolutions

ACTU

ADIL

AKTS

ALUR

ARDT

ARTV

BACQU

BLMZ

BNED

BOSC

BRTX

BTOG

CADL

CCTG

CJET

CRKN

CTNT

DATS

DHCA

DMTK

EDBL

EPRX

EURN

FLAI

FLGC

FWBI

HEAR

HGAS

HOVR

HUBC

IAUX

IONM

ITRM

KSPI

LFST

LPAAU

LRTX

MBIO

MDIA

MGOL

MGRX

MOMO

PERI

PGHL

PIXY

PLBY

PRST

RAYA

RBOT

RZLT

SERV

SGLY

SINT

SOAR

SPIR

SPRB

SPRO

TWFG

VRME

VSME

VVPR

XXII

ZCMD

ZOOZ

Earnings

Press Releases

CCSC Technology International Holdings Limited Reports Financial Results for the First Six Months of Fiscal Year 2024

Small Cap

Opinion

Thinking about buying stock in CXApp, CCSC Technology International, Vroom, Spero Therapeutics, or OptiNose?

CCSC Technology International Holdings Limited Appoints Jung Yi Chiu as Chief Strategy Officer

CCSC Technology International Holdings Limited Announces Plan for New Supply Chain Management Center in Central Europe

New European Supply Chain Center to Enhance Global Growth of Interconnected Products Needed in a Wide Range of Industries: CCSC Technology International Holdings Limited (Nasdaq: CCTG)

CCSC Technology International Holdings Limited Enters into Strategic Cooperation Framework Agreement with Innogetic International Limited

CCSC Technology International Holdings Limited Enters into International Purchase Agreement with SHI / LIGHTCARE-SOLUTIONS ApS

New International Agreements for AI Applications and Healthcare Lighting, Plus Plans for European Supply Chain Center to Serve Varied Tech Industries: CCSC Technology (Nasdaq: CCTG)

CCSC Technology International Holdings Limited Reports Financial Results for Fiscal Year 2024

Comments

CCSC Technology

CCSC Technology (CCTG) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL